Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, February 13). Low-dose semaglutide reduces alcohol consumption and cravings ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of ...

At 9 weeks, semaglutide led to fewer grams of alcohol consumed during a laboratory self-administration task (β= -0.48, 95% CI -0.85 to -0.11, P=0.01) and lower peak breath alcohol concentration ...

Ozempic, Mounjaro may help with alcohol and opioid addiction, study finds : Shots - Health News The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses ...

Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective at helping people lose weight than diet and exercise alone. But some scientists have also ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.